SCHEMBL4067186

SCHEMBL4067186

Cc1noc(C)c1S(=O)(=O)Nc1ccc2c(c1)S(=O)(=O)C=C(c1c(O)c3cc(F)ccc3n(CCC3CC3)c1=O)N2

nearest known ligand 0.49

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
CYP2C9 P11712 3/20 0.49
NR1I2 O75469 1/20 0.49
RORC P51449 1/20 0.39
HTR6 P50406 1/20 0.37
PCK1 P35558 1/20 0.36
ALDH1A1 P00352 3/20 0.35
PKM P14618 1/20 0.35
SMN1; SMN2 Q16637 1/20 0.34
P4HB P07237 3/20 0.33
PTGDR2 Q9Y5Y4 1/20 0.33
HPGD P15428 1/20 0.33
HTT P42858 1/20 0.33
TSHR P16473 1/20 0.33
PARG Q86W56 1/20 0.32
PLK1 P53350 1/20 0.32
ADRA1D P25100 1/20 0.32
ADRA1A P35348 1/20 0.32
ADRA1B P35368 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3921871 0.86 CYP2C9 (0.55) CYP2C9NR1I2RORCPARGPLK1
SCHEMBL4065119 0.86 CYP2C9 (0.54) CYP2C9NR1I2PARGPLK1
SCHEMBL3924684 0.85 CYP2C9 (0.56) CYP2C9NR1I2RORCALDH1A1PTGDR2
SCHEMBL3921480 0.85 CYP2C9 (0.55) CYP2C9NR1I2PTGDR2PARGPLK1
SCHEMBL4065684 0.84 CYP2C9 (0.54) CYP2C9NR1I2PTGDR2PARGPLK1
SCHEMBL4072462 0.84 CYP2C9 (0.52) CYP2C9NR1I2PTGDR2PARGPLK1
SCHEMBL3929718 0.80 CYP2C9 (0.54) CYP2C9NR1I2PTGDR2PLK1
SCHEMBL3922170 0.78 CYP2C9 (0.54) CYP2C9NR1I2PLK1
SCHEMBL3921287 0.78 CYP2C9 (0.72) CYP2C9NR1I2PTGDR2HTTPLK1
SCHEMBL3922147 0.77 CYP2C9 (0.43) CYP2C9NR1I2RORCPARGPLK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1786807-B1 HETEROCYCLIC ANTIVIRAL COMPOUNDS HOFFMANN LA ROCHE (CH) 2009-07-29 EP claimed